Washington | Moderna’s vaccine offers better long-term protection against the severe effects of COVID-19, compared to the Pfizer vaccine, according to a study released Friday by the leading US health agency.
Researchers from the Centers for Disease Prevention and Control (CDC) analyzed a sample of nearly 3,700 adults who were hospitalized with Covid-19 associated with severe symptoms, between March 11 and August 15, 2021, the period leading up to and including the dominance of the delta variable. .
During this period, Moderna’s vaccine was 93% effective against hospitalization, Pfizer’s vaccine was 88% effective and Johnson & Johnson’s vaccine was 68% effective.
Particularly noticeable is the loss of efficacy of the Pfizer vaccine over time: its effectiveness rate decreases from 91% during the period from 14 to 120 days after the injection to 77% for the period after 120 days.
By comparison during the same periods, Moderna’s vaccine efficacy rate increased from 93% to 92%.
Several recent studies point in the same direction, confirming the clear superiority of Moderna’s vaccine over Pfizer’s vaccine.
“Extreme twitteraholic. Passionate travel nerd. Hardcore zombie trailblazer. Web fanatic. Evil bacon geek.”